Robeco Institutional Asset Management B.V. Has $44.76 Million Position in Thermo Fisher Scientific Inc. (TMO)

Robeco Institutional Asset Management B.V. boosted its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 9.3% in the first quarter, HoldingsChannel reports. The firm owned 163,532 shares of the medical research company’s stock after purchasing an additional 13,966 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Thermo Fisher Scientific were worth $44,760,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Capital Financial Planning LLC acquired a new stake in shares of Thermo Fisher Scientific during the 4th quarter worth about $27,000. Hanson McClain Inc. lifted its stake in shares of Thermo Fisher Scientific by 263.9% during the 4th quarter. Hanson McClain Inc. now owns 131 shares of the medical research company’s stock worth $29,000 after buying an additional 95 shares during the last quarter. Truvestments Capital LLC acquired a new stake in shares of Thermo Fisher Scientific during the 1st quarter worth about $29,000. Capital Investment Advisory Services LLC acquired a new stake in shares of Thermo Fisher Scientific during the 4th quarter worth about $35,000. Finally, Liberty Wealth Management LLC acquired a new stake in shares of Thermo Fisher Scientific during the 4th quarter worth about $35,000. 88.84% of the stock is owned by institutional investors and hedge funds.

Shares of Thermo Fisher Scientific stock opened at $267.39 on Wednesday. The company has a market cap of $104.43 billion, a P/E ratio of 24.05, a P/E/G ratio of 1.76 and a beta of 1.11. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.16 and a current ratio of 1.69. Thermo Fisher Scientific Inc. has a 1 year low of $202.83 and a 1 year high of $282.98.



Thermo Fisher Scientific (NYSE:TMO) last posted its earnings results on Wednesday, April 24th. The medical research company reported $2.81 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.74 by $0.07. Thermo Fisher Scientific had a net margin of 12.89% and a return on equity of 17.06%. The firm had revenue of $6.13 billion for the quarter, compared to analyst estimates of $6.04 billion. During the same period in the previous year, the firm posted $2.50 EPS. The company’s revenue for the quarter was up 4.6% compared to the same quarter last year. Equities research analysts forecast that Thermo Fisher Scientific Inc. will post 12.19 EPS for the current year.

The business also recently announced a quarterly dividend, which was paid on Tuesday, April 16th. Investors of record on Friday, March 15th were given a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.28%. The ex-dividend date of this dividend was Thursday, March 14th. This is an increase from Thermo Fisher Scientific’s previous quarterly dividend of $0.17. Thermo Fisher Scientific’s payout ratio is presently 6.83%.

In related news, CFO Stephen Williamson sold 2,500 shares of the business’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $266.00, for a total transaction of $665,000.00. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Marc N. Casper sold 50,713 shares of the business’s stock in a transaction on Tuesday, April 30th. The shares were sold at an average price of $273.21, for a total transaction of $13,855,298.73. Following the transaction, the chief executive officer now owns 302,193 shares in the company, valued at approximately $82,562,149.53. The disclosure for this sale can be found here. Insiders have sold a total of 87,640 shares of company stock worth $23,243,423 in the last quarter. 0.45% of the stock is owned by corporate insiders.

A number of analysts have recently issued reports on the stock. Zacks Investment Research cut shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research note on Monday, May 6th. BTIG Research lifted their price objective on shares of Thermo Fisher Scientific to $310.00 and gave the stock a “buy” rating in a research note on Tuesday, March 26th. Argus lifted their price objective on shares of Thermo Fisher Scientific from $285.00 to $310.00 and gave the stock a “buy” rating in a research note on Wednesday, May 1st. Robert W. Baird lifted their price objective on shares of Thermo Fisher Scientific from $264.00 to $270.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 30th. Finally, Bank of America reiterated a “buy” rating and issued a $300.00 price objective (up previously from $285.00) on shares of Thermo Fisher Scientific in a research note on Tuesday, April 16th. Three equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has given a strong buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $294.77.

COPYRIGHT VIOLATION WARNING: “Robeco Institutional Asset Management B.V. Has $44.76 Million Position in Thermo Fisher Scientific Inc. (TMO)” was first published by Dakota Financial News and is the sole property of of Dakota Financial News. If you are accessing this piece on another website, it was illegally copied and reposted in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://dakotafinancialnews.com/2019/05/15/robeco-institutional-asset-management-b-v-has-44-76-million-position-in-thermo-fisher-scientific-inc-tmo.html.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Further Reading: Dividend

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.